Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00523081 · ClinicalTrials.gov registry record · Phase 3

Study of Adolescence and Depression

A Phase 3 study of Major Depressive Disorder, sponsored by Kaiser Permanente.

Completed
Registry status
Phase 3
Development phase
212
Enrollment target
1
Study location

NCT00523081 is a Phase 3 study of Major Depressive Disorder that has completed, run by Kaiser Permanente. The registered enrollment target is 212 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00523081, a Phase 3 study of Major Depressive Disorder, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
Phase 3
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

STAND is a research study testing a way to help teens between 12-18 years of age who have symptoms of sadness or depression. The study hopes to learn if teens do better if they get five to nine counseling sessions of cognitive behavioral therapy coordinated with the support of their doctor. All teens who join the study will keep seeing their doctor as usual. Teens and a parent are interviewed briefly over the phone to see if they are appropriate for the study. If they qualify for the study, there is an hour-long interview with teen over the telephone and a 30 minute interview with the parent. The interview will include questions about the teen's mood, feelings, behavior, and how they get along with friends and family members. The parent is also asked about his or her own feelings and mood. If the teen and parent join the study, they will be interviewed six more times in the next two years. Half the teens in the study will also meet with a research counselor for five to nine individual, weekly sessions that last about 50 minutes each. Whether a teen attends the weekly counseling sessions is decided by chance, like flipping a coin. If teens are assigned to these sessions, they will learn ways to deal with stress and feel better. If teens take part in the counseling sessions, the study counselor will also talk to the teen's doctor from time to time to help plan for the best possible care.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Active control

Study Locations (1)

Oregon

  • Kaiser Permanente Center for Health Research - Portland

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2006-10
Est. Completion 2014-01
Phase Phase 3

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT00523081

The ClinicalTrials.gov registry entry for NCT00523081 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (44% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00523081 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00523081 about?

NCT00523081 is a clinical study titled "Study of Adolescence and Depression". STAND is a research study testing a way to help teens between 12-18 years of age who have symptoms of sadness or depression. The study hopes to learn if teens do better if they get five to nine counseling sessions of cognitive behavioral therapy coordinated with the support of their doctor. All teen...

What is the current status of trial NCT00523081?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 212 participants. The study started on 2006-10. Estimated completion is 2014-01.

What conditions does trial NCT00523081 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00523081?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Active control (BEHAVIORAL).

Who is sponsoring clinical trial NCT00523081?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00523081 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.